Amgen Investor
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Technology:
CAR-T, Cell_Therapies, Space Medicine
Industry:
AI, Pharma
Headquarters:
Thousand Oaks, California, United States
Founded Date:
1980-01-01
Employees Number:
10001+
Funding Status:
IPO
Investor Type:
Undisclosed
Investment Stage:
N/A
Number Of Exits:
7
Acquisitions Number:
Made Acquisitions
Investors Number:
2
Total Funding:
28500000000
Estimated Revenue:
$10B+
Last Funding Date:
2022-12-12
Last Funding Type:
Post-IPO Debt
Register and Claim Ownership
Suggested by
Amgen